Zhi Tong Cai Jing·2025-11-26 07:03Group 1 - Alibaba Health (00241) shares increased by nearly 3%, currently trading at 6.1 HKD with a transaction volume of 499 million HKD [1] - There is a significant rise in demand for flu-related medications on Alibaba Health's platform, with a more than 500% week-on-week increase in the number of buyers for antiviral drugs [1] - The drug Mabalosavir showed exceptional performance, with a more than 600% increase in the number of buyers compared to the previous week [1] Group 2 - The flu season has started earlier this year, with a rapid increase in flu activity nationwide, particularly in Beijing, which has entered a high incidence period for respiratory infectious diseases [1] - According to Everbright Securities, the demand for cold medications is expected to exceed market expectations in Q4 2025, as flu cases rise with the drop in temperatures [1] - The recent increase in flu cases is likely to raise public and market awareness, driving demand for flu prevention and testing products [1]